273 related articles for article (PubMed ID: 23805191)
1. Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.
Haupt VJ; Daminelli S; Schroeder M
PLoS One; 2013; 8(6):e65894. PubMed ID: 23805191
[TBL] [Abstract][Full Text] [Related]
2. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
Salentin S; Haupt VJ; Daminelli S; Schroeder M
Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
[TBL] [Abstract][Full Text] [Related]
4. Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity.
Park K; Lee S; Ahn HS; Kim D
Mol Biosyst; 2009 Aug; 5(8):844-53. PubMed ID: 19603120
[TBL] [Abstract][Full Text] [Related]
5. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
6. Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing.
Smith RD; Clark JJ; Ahmed A; Orban ZJ; Dunbar JB; Carlson HA
J Mol Biol; 2019 Jun; 431(13):2423-2433. PubMed ID: 31125569
[TBL] [Abstract][Full Text] [Related]
7. Binding site characterization - similarity, promiscuity, and druggability.
Ehrt C; Brinkjost T; Koch O
Medchemcomm; 2019 Jul; 10(7):1145-1159. PubMed ID: 31391887
[TBL] [Abstract][Full Text] [Related]
8. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
Chartier M; Morency LP; Zylber MI; Najmanovich RJ
BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the molecular basis of the ligand promiscuity.
Sturm N; Desaphy J; Quinn RJ; Rognan D; Kellenberger E
J Chem Inf Model; 2012 Sep; 52(9):2410-21. PubMed ID: 22920885
[TBL] [Abstract][Full Text] [Related]
10. Unusual commonality in active site structural features of substrate promiscuous and specialist enzymes.
Thakur D; Pandit SB
J Struct Biol; 2022 Mar; 214(1):107835. PubMed ID: 35104611
[TBL] [Abstract][Full Text] [Related]
11. Method for comparing the structures of protein ligand-binding sites and application for predicting protein-drug interactions.
Minai R; Matsuo Y; Onuki H; Hirota H
Proteins; 2008 Jul; 72(1):367-81. PubMed ID: 18214952
[TBL] [Abstract][Full Text] [Related]
12. The role of flexibility and conformational selection in the binding promiscuity of PDZ domains.
Münz M; Hein J; Biggin PC
PLoS Comput Biol; 2012; 8(11):e1002749. PubMed ID: 23133356
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets.
Saqib U; Kelley TT; Panguluri SK; Liu D; Savai R; Baig MS; Schürer SC
Front Pharmacol; 2018; 9():1201. PubMed ID: 30405416
[TBL] [Abstract][Full Text] [Related]
14. The roles of contact residue disorder and domain composition in characterizing protein-ligand binding specificity and promiscuity.
Tang Y; Sheng X; Stumpf MP
Mol Biosyst; 2011 Dec; 7(12):3280-6. PubMed ID: 22002096
[TBL] [Abstract][Full Text] [Related]
15. Protein functional surfaces: global shape matching and local spatial alignments of ligand binding sites.
Binkowski TA; Joachimiak A
BMC Struct Biol; 2008 Oct; 8():45. PubMed ID: 18954462
[TBL] [Abstract][Full Text] [Related]
16. Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances.
Bolz SN; Schroeder M
Expert Opin Drug Discov; 2023; 18(9):973-985. PubMed ID: 37489516
[TBL] [Abstract][Full Text] [Related]
17. A new protein binding pocket similarity measure based on comparison of clouds of atoms in 3D: application to ligand prediction.
Hoffmann B; Zaslavskiy M; Vert JP; Stoven V
BMC Bioinformatics; 2010 Feb; 11():99. PubMed ID: 20175916
[TBL] [Abstract][Full Text] [Related]
18. Specialized Dynamical Properties of Promiscuous Residues Revealed by Simulated Conformational Ensembles.
Fornili A; Pandini A; Lu HC; Fraternali F
J Chem Theory Comput; 2013 Nov; 9(11):5127-5147. PubMed ID: 24250278
[TBL] [Abstract][Full Text] [Related]
19. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
20. Identify drug repurposing candidates by mining the protein data bank.
Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
